ADNT

Adient plc

Stock · NYSE

Program summary

FieldValueAs ofSource
Current authorization$1.0bn30-Sep-2610-K filed 13-Nov-26
Remaining authorization$435mEST30-Sep-2610-K filed 13-Nov-26
Program expiryn/a—
Repurchased last quarter$45m30-Sep-2610-K filed 13-Nov-26
Has used an ASRNo—

Remaining authorization is estimated: we derive it from reported spend, or convert a share authorization at the latest close. Check the linked filings.

Programs

Authorized onAuthorizedRemainingExpiresTerms
Not found in filings$600m$35mn/aIn November 2022, Adient’s Board of Directors authorized the repurchase of Adient’s ordinary shares up to an aggregate purchase price of $600 million with no expiration date.10-K filed 13-Nov-26
Not found in filings$400m$400mESTn/aIn November 2026, the Board voted to increase the repurchase authorization by $400 million, bringing the total authorization to $1 billion with no expiration date.10-K filed 13-Nov-26

Open-market repurchases

Repurchased per month, USD (≈ shares × average price)
  1. Jul ’26
  2. ≈$40m
    Aug ’26
  3. ≈$5m
    Sep ’26
Month endedSharesAvg price≈ ValueSource
30-Sep-26263,676$18.96$5m10-K filed 13-Nov-26
31-Aug-262,047,093$19.54$40m10-K filed 13-Nov-26
31-Jul-260—$010-K filed 13-Nov-26
Filings through 30-Sep-26· checked 17-Nov-26